🔗 Share this article

Treasury head Reeves has announced she is preparing "focused steps to deal with cost of living issues" in the forthcoming financial statement.

Speaking to the BBC, she stated that curbing price rises is a shared task of both the government and the Bank of England.

The United Kingdom's price growth is projected to be the most elevated among the Group of Seven developed nations this year and the following year.

Possible Utility Bill Interventions

Sources suggest the government could intervene to bring down utility costs, such as by slashing the current 5% level of value-added tax applied on energy supplies.

A further option is to lower some of the policy costs currently included in household expenses.

Budgetary Constraints and Analyst Predictions

The administration will obtain the next assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much scope there is for such actions.

The expectation from the majority of economists is that Reeves will have to declare higher taxes or expenditure reductions in order to fulfill her voluntary borrowing rules.

Earlier on the same day, analysis indicated there was a £22bn shortfall for the chancellor to fill, which is at the lower end of forecasts.

"There's a joint responsibility between the central bank and the administration to bear down further on some of the causes of inflation," Reeves informed the BBC in Washington, at the conferences of the International Monetary Fund and global financial institution.

Revenue Pledges and International Concerns

While much of the focus has been on probable tax increases, the Treasury chief said the latest data from the OBR had not changed her commitment to manifesto promises not to increase rates on income tax, sales tax or National Insurance.

She attributed an "unpredictable world" with increasing geopolitical and trade concerns for the Budget revenue measures, likely to be focused on those "most able to pay."

International Trade Tensions

Referring to concerns about the United Kingdom's trade ties with China she said: "Our national security invariably are paramount."

Last week's statement by China to strengthen export controls on critical minerals and other materials that are key for high-technology production led American leader the US President to threaten an extra 100% tariff on goods from the Asian country, increasing the risk of an all-out commercial conflict between the two global powers.

The American finance chief labeled the Chinese action "economic coercion" and "a international production power grab."

Questioned on considering the American proposal to join its battle with China, Reeves said she was "very concerned" by China's measures and urged the Beijing authorities "not to put up barriers and limit trade."

She said the action was "bad for the world economy and generates additional challenges."

"I believe there are sectors where we must challenge China, but there are also valuable chances to sell into China's economy, including banking sector and other areas of the economic system. We've got to get that equilibrium appropriate."

The chancellor also affirmed she was cooperating with G7 counterparts "regarding our own essential resources approach, so that we are less reliant."

NHS Medicine Pricing and Investment

The Chancellor also recognized that the cost the NHS spends on medicines could rise as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in return for reduced taxes and funding.

Some of the biggest global drug companies have said in recent statements that they are either delaying or abandoning operations in the United Kingdom, with several blaming the low prices they are receiving.

Last month, the government science advisor said the cost the health service spends on drugs would need to go up to stop companies and drug research funding departing from the UK.

The Chancellor informed media: "We have seen because of the cost structure, that clinical trials, new drugs have not been available in the UK in the way that they are in other EU nations."

"Our aim is to guarantee that people receiving treatment from the NHS are able to receive the top critical drugs in the globe. And so we are reviewing these issues, and... looking to secure more funding into Britain."